2024 HKCOG指南:宫颈癌的预防和筛查

2024-12-03 香港妇产科学院 Hong Kong Med J 发表于上海

本文主要总结了HKCOG 2024年版宫颈癌的预防和筛查指南。

中文标题:

2024 HKCOG指南:宫颈癌的预防和筛查

英文标题:

2024 Hong Kong College of Obstetricians and Gynaecologists Guidelines for cervical cancer prevention and screening

发布机构:

香港妇产科学院

发布日期:

2024-12-03

简要介绍:

预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。尽管这些疫苗的功效很高,但宫颈癌筛查仍然是必要的,因为目前的疫苗不能提供充分的保护。本文主要总结了HKCOG 2024年版宫颈癌的预防和筛查指南。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2024 HKCOG指南:宫颈癌的预防和筛查.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1f8121c00a0e74b0, title=2024 HKCOG指南:宫颈癌的预防和筛查, enTitle=2024 Hong Kong College of Obstetricians and Gynaecologists Guidelines for cervical cancer prevention and screening, guiderFrom=Hong Kong Med J, authorId=0, author=, summary=本文主要总结了HKCOG 2024年版宫颈癌的预防和筛查指南。, cover=https://img.medsci.cn/20241204/1733284631644_8538692.jpg, journalId=0, articlesId=null, associationId=1289, associationName=香港妇产科学院, associationIntro=, copyright=0, guiderPublishedTime=Tue Dec 03 00:00:00 CST 2024, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight summary" style="color: #222222;" data-lines="12"><span class="text">预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。尽管这些疫苗的功效很高,但宫颈癌筛查仍然是必要的,因为目前的疫苗不能提供充分的保护。本文主要总结了HKCOG 2024年版宫颈癌的预防和筛查指南。</span></div> </div>, tagList=[TagDto(tagId=1402, tagName=宫颈癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=1402, articleKeyword=宫颈癌, articleKeywordNum=6, guiderKeywordId=1402, guiderKeyword=宫颈癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1318, appHits=44, showAppHits=0, pcHits=258, showPcHits=1273, likes=0, shares=3, comments=5, approvalStatus=1, publishedTime=Wed Dec 04 17:48:00 CST 2024, publishedTimeString=2024-12-03, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Wed Dec 04 09:58:22 CST 2024, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Wed Dec 04 11:57:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2024 HKCOG指南:宫颈癌的预防和筛查.pdf)])
2024 HKCOG指南:宫颈癌的预防和筛查.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2245044, encodeId=d2572245044fc, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d60f9150168, createdName=ms2000001668843882, createdTime=Thu Dec 26 22:27:34 CST 2024, time=2024-12-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2241590, encodeId=39882241590d8, content=筛查有必要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13579565485, createdName=ms1000000276339492, createdTime=Mon Dec 09 23:20:39 CST 2024, time=2024-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241029, encodeId=fc0a2241029e5, content=尽管疫苗的功效很高,但宫颈癌筛查仍然是必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Fri Dec 06 06:23:39 CST 2024, time=2024-12-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2240915, encodeId=fc2f224091525, content=预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Thu Dec 05 10:24:21 CST 2024, time=2024-12-05, status=1, ipAttribution=山东省)]
    2024-12-26 ms2000001668843882 来自河南省

    很有帮助

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2245044, encodeId=d2572245044fc, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d60f9150168, createdName=ms2000001668843882, createdTime=Thu Dec 26 22:27:34 CST 2024, time=2024-12-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2241590, encodeId=39882241590d8, content=筛查有必要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13579565485, createdName=ms1000000276339492, createdTime=Mon Dec 09 23:20:39 CST 2024, time=2024-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241029, encodeId=fc0a2241029e5, content=尽管疫苗的功效很高,但宫颈癌筛查仍然是必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Fri Dec 06 06:23:39 CST 2024, time=2024-12-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2240915, encodeId=fc2f224091525, content=预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Thu Dec 05 10:24:21 CST 2024, time=2024-12-05, status=1, ipAttribution=山东省)]
    2024-12-09 ms1000000276339492 来自安徽省

    筛查有必要

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2245044, encodeId=d2572245044fc, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d60f9150168, createdName=ms2000001668843882, createdTime=Thu Dec 26 22:27:34 CST 2024, time=2024-12-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2241590, encodeId=39882241590d8, content=筛查有必要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13579565485, createdName=ms1000000276339492, createdTime=Mon Dec 09 23:20:39 CST 2024, time=2024-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241029, encodeId=fc0a2241029e5, content=尽管疫苗的功效很高,但宫颈癌筛查仍然是必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Fri Dec 06 06:23:39 CST 2024, time=2024-12-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2240915, encodeId=fc2f224091525, content=预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Thu Dec 05 10:24:21 CST 2024, time=2024-12-05, status=1, ipAttribution=山东省)]
    2024-12-06 ms5000000707039972 来自山东省

    尽管疫苗的功效很高,但宫颈癌筛查仍然是必要的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2245044, encodeId=d2572245044fc, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d60f9150168, createdName=ms2000001668843882, createdTime=Thu Dec 26 22:27:34 CST 2024, time=2024-12-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2241590, encodeId=39882241590d8, content=筛查有必要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13579565485, createdName=ms1000000276339492, createdTime=Mon Dec 09 23:20:39 CST 2024, time=2024-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241029, encodeId=fc0a2241029e5, content=尽管疫苗的功效很高,但宫颈癌筛查仍然是必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Fri Dec 06 06:23:39 CST 2024, time=2024-12-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2240915, encodeId=fc2f224091525, content=预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db489112955, createdName=ms5000000707039972, createdTime=Thu Dec 05 10:24:21 CST 2024, time=2024-12-05, status=1, ipAttribution=山东省)]
    2024-12-05 ms5000000707039972 来自山东省

    预防宫颈癌的最佳方法是为女孩接种预防性人乳头瘤病毒(HPV)疫苗。

    0

拓展阅读

Pediatric Blood Cancer:肿瘤康复儿童可以接种HPV疫苗吗?

研究显示,尽管建议9岁以上的女性儿童癌症幸存者(CCS)和造血干细胞移植(HSCT)受者接种 HPV 疫苗,但家长的接受度仍不明确。

超90%患者缓解!朱笕青团队带来宫颈癌一线治疗新方案

2 期试验显示,替雷利珠单抗联合低剂量贝伐珠单抗及标准化疗,治疗持续性、复发性或转移性宫颈癌,客观缓解率达 91.5%,中位无进展生存期 22.6 个月,安全性可控。

STTT:天津医科大学肿瘤医院刘文欣团队发表局晚期宫颈癌新辅助免疫化疗临床研究成果,pCR率达66.7%!

该研究展示了替雷利珠单抗联合化疗的新辅助治疗方案在IB3/IIA2期宫颈癌中显示出令人鼓舞的抗肿瘤活性、安全可控,这为局晚期宫颈癌(LACC)患者提供了一种新的治疗选择。

免疫重建良好,风险为何不减?新研究揭示HIV女性持续宫颈癌威胁

本研究旨在探讨在高效、依从性良好的现代ART治疗背景下,ART治疗时长和CD4+细胞计数是否会影响这种风险。

大咖谈 | 帕博利珠单抗助力局部晚期宫颈癌管理

2024年NMPA批准帕博利珠单抗联合CRT用于FIGO2014 III-IVA期患者,并获NCCN,CSCO等指南推荐(1类证据),标志免疫治疗正式纳入LACC一线方案。

2010 NACB医学实践指南:肝癌、膀胱癌、子宫颈癌、胃癌肿瘤标志物的应用

美国临床生化科学院(NACB,The National Academy of Clinical Biochemistry) · 2010-01-01

2010ESMO临床实践指南:宫颈癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2010 宫颈癌规范化诊治指南

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-11-16

2011SOGC 低资源地区宫颈癌的预防

加拿大妇产科医生协会(SOGC,Society of Obstetricians and Gynaecologists of Canada) · 2011-03-01

2011 ESUR指南:宫颈癌MRI分期

欧洲泌尿生殖放射学会(ESUR,European Society of Urogenital Radiology) · 2011-05-10

2011 子宫颈癌诊断指南

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01